MyBCTeam

What side effects can you expect from Kadcyla when planning to return to work full-time?

Kadcyla (T-DM1) is a targeted therapy that combines trastuzumab with chemotherapy, delivering treatment directly to HER2-positive breast cancer cells. This approach helps reduce damage to healthy tissue compared to traditional Show Full Answer

What side effects can you expect from Kadcyla when planning to return to work full-time?

Kadcyla (T-DM1) is a targeted therapy that combines trastuzumab with chemotherapy, delivering treatment directly to HER2-positive breast cancer cells. This approach helps reduce damage to healthy tissue compared to traditional chemotherapy.

Since Kadcyla is typically given after you've completed radiation, you'll want to manage any lingering side effects from radiation while starting this new treatment. The targeted nature of Kadcyla may mean fewer overall side effects than standard chemotherapy, but everyone responds differently.

When planning your return to work, consider:
- Starting part-time if possible to gauge your energy levels
- Scheduling treatments at times that allow for recovery days
- Communicating with your employer about flexibility needs
- Tracking your side effects to identify patterns

Be sure to discuss your work plans with your oncology team. They can help you understand what to expect and may adjust your treatment schedule to support your goals. Listen to your body and don't hesitate to ask for accommodations if needed during this transition.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

Kadcyle Extends Survival for Early HER2-Positive Breast Cancer